Polygenic Risk Scores Driving Clinical Change in Glaucoma

Glaucoma is a clinically heterogeneous disease and the world's leading cause of irreversible blindness. Therapeutic intervention can prevent blindness but relies on early diagnosis, and current clinical risk factors are limited in their ability to predict who will develop sight-threatening glau...

Full description

Saved in:
Bibliographic Details
Published in:Annual review of genomics and human genetics 2024-08, Vol.25 (1), p.287-308
Main Authors: Kolovos, Antonia, Hassall, Mark M, Siggs, Owen M, Souzeau, Emmanuelle, Craig, Jamie E
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glaucoma is a clinically heterogeneous disease and the world's leading cause of irreversible blindness. Therapeutic intervention can prevent blindness but relies on early diagnosis, and current clinical risk factors are limited in their ability to predict who will develop sight-threatening glaucoma. The high heritability of glaucoma makes it an ideal substrate for genetic risk prediction, with the bulk of risk being polygenic in nature. Here, we summarize the foundations of glaucoma genetic risk, the development of polygenic risk prediction instruments, and emerging opportunities for genetic risk stratification. Although challenges remain, genetic risk stratification will significantly improve glaucoma screening and management.
ISSN:1527-8204
1545-293X
1545-293X
DOI:10.1146/annurev-genom-121222-105817